Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 234, pseudogene (RN7SL234P)

Target
RN7SL234P
Molecular classification
Other, Non-coding RNA pseudogene
01

Overview

**RN7SL234P** (RNA, 7SL, cytoplasmic 234, pseudogene) is a non-coding RNA sequence in the human genome classified as a pseudogene related to the 7SL RNA, the RNA component of the signal recognition particle (SRP)[3][4]. 7SL RNA plays a key role in the targeting and translocation of secretory proteins across the endoplasmic reticulum membrane, but the RN7SL234P pseudogene is a non-functional, truncated or mutated copy generated through retrotransposition events[2][5]. There are several hundred such 7SL pseudogenes in the genome, most of which do not produce functional RNA and do not participate in signal recognition or any known biological process[2][5]. RN7SL234P is not considered a therapeutic target, as pseudogenes generally lack protein product and known biological function.\n\n**Key issues:** \n- RN7SL234P is a pseudogene, not a protein-coding gene, enzyme, receptor, or any established therapeutic target[2][3][5].\n- No evidence links it to disease, drug interaction, or functional biological activity[2][3].\n- Most "7SL RNA" pseudogenes are non-expressed and do not have roles in physiological or pathological processes[2][5]. \n- Standard classification databases (Ensembl, GeneCards) list its molecular type as "misc RNA" or pseudogene, not as a functional target[3][4].

Other names
RN7SL234PRNA 7SL cytoplasmic 234 pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 234, pseudogene (RN7SL234P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 234, pseudogene (RN7SL234P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call